[go: up one dir, main page]

NL8702533A - (+)-1-isopropylamino-3-0-(pyrrool-1-yl)-fenoxy-2-propanol of een zout daarvan, een werkwijze ter bereiding van het propanolderivaat en zouten ervan alsmede farmaceutische preparaten, die deze verbindingen bevatten. - Google Patents

(+)-1-isopropylamino-3-0-(pyrrool-1-yl)-fenoxy-2-propanol of een zout daarvan, een werkwijze ter bereiding van het propanolderivaat en zouten ervan alsmede farmaceutische preparaten, die deze verbindingen bevatten. Download PDF

Info

Publication number
NL8702533A
NL8702533A NL8702533A NL8702533A NL8702533A NL 8702533 A NL8702533 A NL 8702533A NL 8702533 A NL8702533 A NL 8702533A NL 8702533 A NL8702533 A NL 8702533A NL 8702533 A NL8702533 A NL 8702533A
Authority
NL
Netherlands
Prior art keywords
propanol
isopropylamino
phenoxy
pyrrol
pharmaceutical preparations
Prior art date
Application number
NL8702533A
Other languages
English (en)
Dutch (nl)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4235/86A external-priority patent/CH668185A5/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NL8702533A publication Critical patent/NL8702533A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL8702533A 1986-10-24 1987-10-23 (+)-1-isopropylamino-3-0-(pyrrool-1-yl)-fenoxy-2-propanol of een zout daarvan, een werkwijze ter bereiding van het propanolderivaat en zouten ervan alsmede farmaceutische preparaten, die deze verbindingen bevatten. NL8702533A (nl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH423586 1986-10-24
CH4235/86A CH668185A5 (de) 1986-10-24 1986-10-24 Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten.
CH17887 1987-01-19
CH17887 1987-01-19
CH92687 1987-03-12
CH92587 1987-03-12
CH92687 1987-03-12
CH92587 1987-03-12

Publications (1)

Publication Number Publication Date
NL8702533A true NL8702533A (nl) 1988-05-16

Family

ID=27427782

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8702533A NL8702533A (nl) 1986-10-24 1987-10-23 (+)-1-isopropylamino-3-0-(pyrrool-1-yl)-fenoxy-2-propanol of een zout daarvan, een werkwijze ter bereiding van het propanolderivaat en zouten ervan alsmede farmaceutische preparaten, die deze verbindingen bevatten.

Country Status (16)

Country Link
EP (1) EP0265388A1 (sv)
KR (1) KR880005094A (sv)
AT (1) ATA281087A (sv)
BE (1) BE1002060A3 (sv)
DE (1) DE3735641A1 (sv)
DK (1) DK554887A (sv)
FI (1) FI874643A (sv)
FR (1) FR2605629A1 (sv)
GB (1) GB2197315A (sv)
GR (1) GR871634B (sv)
HU (1) HUT45492A (sv)
IE (1) IE872860L (sv)
NL (1) NL8702533A (sv)
NO (1) NO874425L (sv)
PT (1) PT85976B (sv)
SE (1) SE8704093L (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265388A1 (de) * 1986-10-24 1988-04-27 Ciba-Geigy Ag Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung
JPH02131465A (ja) * 1988-07-18 1990-05-21 Nippon Tokushu Noyaku Seizo Kk 1−フエニルピロール類及び除草剤としての利用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204241A1 (es) * 1973-03-09 1975-12-10 Ciba Geigy Ag Procedimiento para preparar compuestos derivados del 1-pirrolil(1)-fenoxi-2-hidroxi-3-alquilamino-propano y del 1-pirrolil-(1)-fenoxi-3-hidroxi-3-morfolino-propano
DE2835438A1 (de) * 1978-08-12 1980-03-06 Basf Ag Aminopropanolderivate des 2-(o-hydroxyphenyl)-pyrrols
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
EP0265388A1 (de) * 1986-10-24 1988-04-27 Ciba-Geigy Ag Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung

Also Published As

Publication number Publication date
PT85976B (de) 1990-01-19
FR2605629A1 (fr) 1988-04-29
GR871634B (en) 1988-02-24
FI874643A0 (fi) 1987-10-21
SE8704093D0 (sv) 1987-10-21
IE872860L (en) 1988-04-24
DK554887D0 (da) 1987-10-23
ATA281087A (de) 1989-01-15
KR880005094A (ko) 1988-06-28
BE1002060A3 (fr) 1990-06-12
PT85976A (de) 1987-11-01
NO874425L (no) 1988-04-25
HUT45492A (en) 1988-07-28
GB2197315A (en) 1988-05-18
DK554887A (da) 1988-04-05
DE3735641A1 (de) 1988-04-28
FI874643A (fi) 1988-04-25
EP0265388A1 (de) 1988-04-27
SE8704093L (sv) 1988-04-25
NO874425D0 (no) 1987-10-23

Similar Documents

Publication Publication Date Title
EP2202225A1 (fr) Nouveau procédé de synthèse de l'ivabradine et de ses sels d'addition à un acide pharmaceutiquemenet acceptable
CH644348A5 (fr) Amino-ethers oxydes, leur procede de preparation et medicament les contenant.
CH683996A5 (fr) Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
EP0351255B1 (fr) Dérivés de [(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
WO2008037881A2 (fr) Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique.
CA2630655A1 (fr) Derives de isoquinoline et benzo[h]isoquinoline, leur preparation et leur utilisation en therapeutique en tant qu'antagonistes du recepteur de l'histamine h3
JP2004331669A (ja) 欝病、不安神経症およびパ−キンソン病を治療するための1−アリールシクロアルキルスルフィド、スルホキシドおよびスルホン
NL8702533A (nl) (+)-1-isopropylamino-3-0-(pyrrool-1-yl)-fenoxy-2-propanol of een zout daarvan, een werkwijze ter bereiding van het propanolderivaat en zouten ervan alsmede farmaceutische preparaten, die deze verbindingen bevatten.
EP0074873B1 (fr) Dérivés de phénoxy-3 propanol-2, leur préparation et leur application en thérapeutique
EP0322263B1 (fr) Carbamates tricycliques, leur procédé de préparation et leur application en thérapeutique
FR2669030A1 (fr) Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0891358A1 (fr) Composes derives d'oxazolidin-2-one, leur procede de preparation et leur application en therapeutique
IE58121B1 (en) 1,3-Disubstituted piperdine compounds as neuroleptic agents
RU2203896C2 (ru) Производное пиперидинилметилоксазолидинона, способ его получения, фармацевтическая композиция и способ ее получения
EP1187824B1 (fr) Derives de [(2-substitue-5-[3-thienyl)-benzyl]-[2-([2-isopropoxy-5-fluoro]-phenoxy)-ethyl]-amine, leur procede de preparation et leur utilisation a titre de medicaments
WO1999031097A1 (fr) Derives d'imidazole en tant qu'antagonistes des recepteurs muscariniques m3
FR2741071A1 (fr) Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2745572A1 (fr) Nouveaux sulfonamides derives de benzylamines, leurs sels, ainsi que leurs procedes de fabrication, les compositions pharmaceutiques et leur utilisation comme medicaments
WO2002068399A1 (fr) Derives d'arylcarbamates, preparation et utilisations
SK286671B6 (sk) Spôsob prípravy derivátov 2-(2-arylmorfolin-2-yl)etanolu a medziprodukty na ich prípravu
FR2690917A1 (fr) Aminoesters, leur procédé de préparation et leur application en thérapeutique.
FR2700540A1 (fr) alpha-méthyl-(R)-tryptophyl-arylcycloalkylalkylamides ligands aux récepteurs des gastrines, leur préparation et leur utilisation en thérapeutique.
CA2393995C (fr) Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2610322A1 (fr) Nouveaux derives de la pilocarpine, leur preparation et leur utilisation comme medicaments
JP2000239274A (ja) 新規ナフチリジン誘導体の製造法

Legal Events

Date Code Title Description
BV The patent application has lapsed